Saba Capital Management »

Conduit Pharmaceuticals shares owned by Saba Capital Management

Quarter-by-quarter ownership of Conduit Pharmaceuticals (CDTTW) shares owned by Saba Capital Management from 13F filings

Historical chart of Saba Capital Management investment in Conduit Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Conduit Pharmaceuticals held by Saba Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Conduit Pharmaceuticals by Saba Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $25k 765k 0.03
2024-03-31 $61k 765k 0.08
2023-12-31 $57k 765k 0.07
2023-09-30 $34k 765k 0.05

More positions owned by Saba Capital Management

Ishares Tr Russell 2000 Etf Call Option (IWM)
Blackrock Esg Cap Allc Term Shs Ben Int (ECAT)
Blackrock Innovation And Grw Shs Ben Int (BIGZ)
Blackrock Health Sciences Te Com Shs (BMEZ)
Blackrock Capital Allocation Trust (BCAT)
Adams Express Company (ADX)
Pimco Dynamic Income Strateg Com Shs Ben Int (PDX)
Blackrock Science & Technolo Shs Ben Int (BSTZ)
Nuveen CA Dividend Advantage Muni. Fund (NAC)
Gabelli Dividend & Income Trust (GDV)
Mainstay Cbre Global (MEGI)
Nuveen Nj Div Advantage Mun (NXJ)
Neuberger Berman Next Genera Common Stock (NBXG)
American Airls Put Option (AAL)
Invesco Van Kampen Muni Opp Trust (VMO)

View all positions for Saba Capital Management

Top funds holding Conduit Pharmaceuticals

Highbridge Capital Management
Polar Securities
Saba Capital Management
MMCAP International Inc. SPC
Exos Asset Management
Clear Street
D. E. Shaw & Co
Wolverine Asset Management
Atw Spac Management
Arena Investors
Mizuho Securities USA
CNH Partners
Periscope Capital
Cowen And Company
Whitebox Advisors

View all funds holding Conduit Pharmaceuticals